This Article Full Text Full Text (PDF) Data Supplement Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hoffmann, E. Search for Related Content PubMed PubMed Citation Articles by Hoffmann, E. Related Collections Pacemaker Arrhythmias, clinical electrophysiology, drugs

(Circulation. 2006;113:1933-1941.)
© 2006 American Heart Association, Inc.

Arrhythmia/Electrophysiology

New Insights Into the Initiation of Atrial Fibrillation

A Detailed Intraindividual and Interindividual Analysis of the Spontaneous Onset of Atrial Fibrillation Using New Diagnostic Pacemaker Features

Ellen Hoffmann, MD; Neil Sulke, MD; Nils Edvardsson, MD; Jacob Ruiter, MD; Thorsten Lewalter, MD; Alessandro Capucci, MD; Andreas Schuchert, MD; Sabine Janko, MD; John Camm, MD, on behalf of the Atrial Fibrillation Therapy (AFT) Trial Investigators

From Klinikum der Universität München-Großhadern (E.H., S.J.), München, Germany; Eastbourne District Hospital (N.S.), Eastbourne, United Kingdom; Sahlgrenska Universitetssjukhuset (N.E.), Göteborg, Sweden; Medisch Centrum Alkmaar (J.R.), Alkmaar, the Netherlands; Universitätsklinikum Bonn (T.L.), Bonn, Germany; Ospedale Civile Piacenza (A.C.), Piacenza, Italy; Universitätsklinikum Hamburg-Eppendorf (A.S.), Hamburg, Germany; and St. Georges Hospital and Medical School (J.C.), London, United Kingdom.

Correspondence to Professor Dr Ellen Hoffmann, Städtisches Klinikum München GmbH, Klinikum Bogenhausen, Englschalkinger Straße 77, 81925 München, Germany. E-mail ellen.hoffmann{at}kh-bogenhausen.de

Received June 13, 2005; revision received February 24, 2006; accepted March 2, 2006.

Background— This study investigated onset scenarios of atrial fibrillation (AF), the first phase of the Atrial Fibrillation Therapy (AFT) trial, to determine potential arrhythmogenic triggers as targets for atrial pacing algorithms that have been proposed for prevention of AF.

Methods and Results— Ninety-eight patients (58 men; age 65±11 years) with recurrent, symptomatic, drug-refractory AF and a conventional pacemaker indication in 31 of 98 received a dual-chamber pacemaker. Using novel diagnostic pacemaker features AF onset scenarios were prospectively evaluated in 612 AF episodes during a 2-month monitoring period, with atrial pacing limited to 40 bpm. The most common onset scenario was premature atrial complexes (PACs) before AF (48% onsets per patient), followed by bradycardia (33%), sudden onset (17%), and tachycardia (0%). Combinations of onset scenarios were frequent (median 2 different scenarios per patient). A main study finding was the significance of repetitive AF, with 33% of onsets per patient being initiated within 5 minutes of a previous AF episode. Sudden onsets were more frequent among patients with than without repetitive AF (24% versus 0% onsets per patient, P=0.011), whereas the proportion of PACs before AF was not statistically different (50% versus 37%, P=0.52); however, patients with repetitive AF had more PACs per hour (72 versus 29, P=0.023) and a higher number of AF episodes per day (17 versus 0, P=0.001) and were more likely to have at least 1 PAC-related onset (90% versus 53%, P<0.0001).

Conclusions— Novel diagnostic pacemaker features allowed a detailed individual analysis of rate and rhythm changes before AF and thus uncovered a substantial intraindividual and interindividual variability of AF onset scenarios.

---

 

CLINICAL PERSPECTIVE

This article has been cited by other articles:

				S. Janko and E. Hoffmann Atrial antitachycardia pacing: do we still need to talk about it? Europace, August 1, 2009; 11(8): 977 - 979. [Full Text] [PDF]

				Task Force members, M. Brignole, P. Vardas, E. Hoffman, H. Huikuri, A. Moya, R. Ricci, N. Sulke, W. Wieling, EHRA Scientific Documents Committee, et al. Indications for the use of diagnostic implantable and external ECG loop recorders Europace, May 1, 2009; 11(5): 671 - 687. [Full Text] [PDF]

				A. J. Camm, P. Kirchhof, G. Y.H. Lip, I. Savelieva, and S. Ernst CHAPTER 29 Atrial Fibrillation ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]

				M. E.W. Hemels, J. H. Ruiter, G. P. Molhoek, N. J.G.M. Veeger, A. C.P. Wiesfeld, A. V. Ranchor, M. van Trigt, A. Pilmeyer, I. C. Van Gelder, and for The Features in AT500TM study; Chances for pat Right atrial preventive and antitachycardia pacing for prevention of paroxysmal atrial fibrillation in patients without bradycardia: a randomized study Europace, March 1, 2008; 10(3): 306 - 313. [Abstract] [Full Text] [PDF]

				A.J. Camm, N. Sulke, N. Edvardsson, P. Ritter, B.A. Albers, J.H. Ruiter, T. Lewalter, P.A. Capucci, E. Hoffmann, and on behalf of the AFTherapy investigators Conventional and dedicated atrial overdrive pacing for the prevention of paroxysmal atrial fibrillation: the AFTherapy study Europace, December 1, 2007; 9(12): 1110 - 1118. [Abstract] [Full Text] [PDF]

				C. W. Israel What is the role of the pacing rate in the prevention of atrial tachyarrhythmias? Europace, November 1, 2007; 9(11): 999 - 1001. [Full Text] [PDF]

				N. Sulke, J. Silberbauer, L. Boodhoo, N. Freemantle, K. Kamalvand, S. O'Nunain, D. Hildick-Smith, G. W. Lloyd, N. R. Patel, and V. Paul The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation: the Pacemaker Atrial Fibrillation Suppression (PAFS) study Europace, September 1, 2007; 9(9): 790 - 797. [Abstract] [Full Text] [PDF]